A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies.

A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies.

<h4>Background</h4>Stromal derived factor-1α (SDF-1α/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemi...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel I Bromage, Stasa Taferner, Mahesh Pillai, Derek M Yellon, Sean M Davidson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0174447&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items